Literature DB >> 8221136

CCK-8 excites oxytocin-secreting neurons in the paraventricular nucleus in rats--possible involvement of noradrenergic pathway.

Y Ueta1, H Kannan, T Higuchi, H Negoro, H Yamashita.   

Abstract

Systemic administration of CCK-8 increased plasma oxytocin (OXT) level in rats anesthetized with a mixture of urethane and alpha-chloralose. Extracellular recordings were made from magnocellular neurosecretory neurons in the paraventricular nucleus (PVN) of the hypothalamus in anesthetized rats to examine the effects of CCK-8 on the firing of PVN neurons. Thirteen out of 16 nonphasic neurons (putative OXT-secreting neurons) were excited by intravenous and/or intraperitoneal administration of CCK-8. By contrast, 8 out of 10 phasic cells, vasopressin(AVP)-secreting cells, were inhibited by systemic administration of CCK-8. Four out of five nonneurosecretory neurons in the PVN were excited by the administration of CCK-8. Moreover, microiontophoretically applied phentolamine blocked the excitatory responses induced by CCK-8 in nonphasic neurons. We measured extracellular noradrenaline (NA) level in the PVN, using in vivo microdialysis. Intravenous administration of CCK-8 induced NA release in the PVN. These results suggest that CCK-8 activates the excitatory afferent pathway to putative OXT-secreting neurons in the PVN which may, at least in part, be involved in the central noradrenergic projection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221136     DOI: 10.1016/0361-9230(93)90290-r

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

Review 1.  Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions.

Authors:  Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-20       Impact factor: 3.619

2.  Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.

Authors:  C H Brown; G Munro; N P Murphy; G Leng; J A Russell
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

3.  Hindbrain oxytocin receptors contribute to the effects of circulating oxytocin on food intake in male rats.

Authors:  Jacqueline M Ho; Vishwanath T Anekonda; Benjamin W Thompson; Mingyan Zhu; Robert W Curry; Bang H Hwang; Gregory J Morton; Michael W Schwartz; Denis G Baskin; Suzanne M Appleyard; James E Blevins
Journal:  Endocrinology       Date:  2014-05-30       Impact factor: 4.736

4.  Sulfated cholecystokinin-8 activates phospho-mTOR immunoreactive neurons of the paraventricular nucleus in rats.

Authors:  Vanessa Lembke; Miriam Goebel; Lisa Frommelt; Tobias Inhoff; Reinhardt Lommel; Andreas Stengel; Yvette Taché; Carsten Grötzinger; Norbert Bannert; Bertram Wiedenmann; Burghard F Klapp; Peter Kobelt
Journal:  Peptides       Date:  2010-10-07       Impact factor: 3.750

Review 5.  Oxytocin as a potential pharmacological tool to combat obesity.

Authors:  Pawel K Olszewski; Emily E Noble; Luis Paiva; Yoichi Ueta; James E Blevins
Journal:  J Neuroendocrinol       Date:  2022-02-22       Impact factor: 3.870

Review 6.  Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.

Authors:  C H Brown; J S Bains; M Ludwig; J E Stern
Journal:  J Neuroendocrinol       Date:  2013-08       Impact factor: 3.627

Review 7.  Visceral sensory inputs to the endocrine hypothalamus.

Authors:  Linda Rinaman
Journal:  Front Neuroendocrinol       Date:  2007-02-22       Impact factor: 8.606

8.  Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus.

Authors:  Ted D Hoyda; Mark Fry; Rexford S Ahima; Alastair V Ferguson
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

Review 9.  Fluorescent visualization of oxytocin in the hypothalamo-neurohypophysial system.

Authors:  Hirofumi Hashimoto; Takanori Matsuura; Yoichi Ueta
Journal:  Front Neurosci       Date:  2014-07-23       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.